DC-MEETINGPLAY/AVENTRI
6.1.2022 16:02:13 CET | Business Wire | Press release
Today, market leading event software companies MeetingPlay and Aventri announce that they have merged and received a growth equity investment from Sunstone Partners and Camden Partners. Combining the strengths of both companies, they will forge a new path as the dominant, full-service event software provider.
This new event software powerhouse will blend visionary technology and best-in-class service to close all gaps in the planning process, offering the most complete full-service solution for meetings and events of all sizes, from conferences of 200,000+ to meetings with less than 100 attendees. The combined company will become one of the world’s largest event technology companies, servicing customers on a global scale.
In conjunction with the merger, Eric Lochner has been named Chief Executive Officer of the new company. Eric has over 25 years of experience in building technology and technology-enabled services companies, with an impressive record of mergers and acquisitions. “We are excited to bring these two inventive companies together to create a new cutting-edge experience for the meetings and events industry,” said Lochner. “We have a strong opportunity to deepen the process of hosting in-person, hybrid and virtual events and are excited to be able to better support meeting planners and event organizers while offering a wider range of products and experiences.”
Each year, MeetingPlay and Aventri power a combined total of more than 50,000 events, service over 10,000 companies, and elevate the attendee experience for more than 7 million attendees. The unrivaled creativity, service, and ingenuity of each company will be at the forefront of their new company and brand, which will enable their enterprise customers to grow their businesses with best-in-class events of all types and sizes.
Founded in 2011, MeetingPlay is an award-winning technology pioneer, centered around creating innovative solutions for premier in-person, virtual, and hybrid events. The company is known for pushing the envelope on technology advancements and has successfully powered many of the largest, most complex global events to date across numerous industries.
Aventri is the global leader in data-driven, end-to-end event management solutions for virtual, hybrid, and in-person events. The company was founded in 2008. Today, the award-winning platform provides a suite of premium solutions for the entire event lifecycle, from venue sourcing to event marketing, registration, onsite technology, strategic meetings management, data security and privacy, and ROI reporting.
“Two great companies are coming together, leveraging secular tailwinds to increase market share and expand their innovative software capabilities to benefit top companies and brands,” said Sunstone Partners Co-Founder and Managing Director, Michael Biggee. “We’re delighted to continue partnering with them on their exciting future as one company.”
This news comes at a critical time in the meetings and events industry when planners and organizers are seeking to adopt the benefits of virtual and hybrid gatherings while using fewer software integrations. The two companies will integrate their proprietary software platforms to elevate event experiences through a robust lineup of unmatched products to leading companies in the technology, financial services, travel, hospitality, health services, and association markets. This, paired with the highest level of service, will deliver a richer experience for both planners and attendees, while setting the brand apart from competitors. Highlighted capabilities include:
- Event Marketing Website and Registration to create a seamless attendee journey from beginning to end.
- A Virtual and Hybrid Event Platform, which uses novel technology to create lifelike experiences for virtual attendees. The platform provides virtual and onsite attendees with unified engagement features like chat, Q&A, network matchmaking, and video conferencing that enables participants in the same room and across the world to connect instantly.
- A Mobile App and imaginative Onsite Event Solutions, which enrich the attendee experience start to finish, boost engagement, and deliver ROI metrics, while keeping participants safe.
Co-Founder and former MeetingPlay CEO Joe Schwinger, and Co-Founder and former MeetingPlay COO Lisa Vann will remain with the new company and undertake executive roles to continue enhancing the event technology industry and working with their valued customers. Former Aventri CEO Jim Sharpe will remain a shareholder and advisor to the new company.
For more information about MeetingPlay, visit www.meetingplay.com and follow along on Instagram , Twitter , Facebook and LinkedIn .
For more information about Aventri, visit www.aventri.com and follow along on Instagram , Twitter , Facebook and LinkedIn .
About MeetingPlay
MeetingPlay is a Washington D.C.-based technology company focused on creating groundbreaking solutions for in-person, virtual, and hybrid events. With every meeting and event, MeetingPlay creates transformative experiences that enables their customers, attendees, and sponsors to make valuable, face-to-face connections. Market-leading companies entrust MeetingPlay to solve their biggest event challenges. Learn more at meetingplay.com
.
About Aventri
Aventri is the global leader in data-driven, end-to-end event and meeting management solutions for virtual, hybrid, and in-person events. Their award-winning SaaS platform, virtual technology, and best-in-class service offerings have enabled more than 30,000 event professionals annually to plan, promote, deliver, measure, and optimize their events. Aventri’s fully integrated platform’s capabilities include virtual delivery, networking, venue sourcing, registration, marketing, logistics, onsite services, attendee engagement, and data analytics. Headquartered in the United States, the company has offices in the United Kingdom, Europe, and Asia Pacific and has delivered customer events in over 120 countries. Learn more at aventri.com
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220106005160/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom